Foresite Capital Management I, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+39,412
(38.3%)
New positions
3
Sold out positions
0
Turnover %
12.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KPTI | 16,364 | 50.2% |
| OREXIGEN THERAPEUTICS INC | 8,125 | NEW |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 5,908 | NEW |
| KERYX BIOPHARMACEUTICALS | 5,367 | 31.6% |
| IGNYTA INC | 4,150 | NEW |
| XNCR | 2,124 | 28.3% |
| TLPH | 966 | 6.2% |
Top Reduces (Value $000, Stocks/ETFs)
| XLRN | -1,893 | -72.4% |
| AMBIT BIOSCIENCES CORP | -1,081 | -5.4% |
| NVAX | -788 | -11.5% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
906
(0.6% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|